ASEAN Countries Make Progress in Harmonizing Pharmaceutical Quality Guidelines
This article was originally published in The Gold Sheet
Executive Summary
Southeast Asian authorities are making progress in aligning pharmaceutical approval and quality regulations with ICH, but country-specific requirements are still an impediment.
You may also be interested in...
Asia-Pacific Region Begins Adopting Lifecycle Approaches To Process Validation
Pharmaceutical manufacturers in India should be aware that inspectors may be looking to see that lifecycle approaches to process validation have been used in their systems with the country’s adoption of a WHO guideline on process validation. ASEAN is also about to issue guidance that tells manufacturers how to design a lifecycle approach to validating vaccine manufacturing processes.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.